Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumors: A cost‐effectiveness study
Desar, Ingrid M.E., Zuidema, Sander, Erp, Nielka P., Kievit, WietskeLanguage:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13990
Date:
May, 2019
File:
PDF, 555 KB
english, 2019